Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell I Genex Finalizes Coventry Workers' Comp Services Acquisition
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
PDF
News Release
Mitchell Genex Finalizes Coventry Workers’ Comp Services Acquisition
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
Workers' Comp
News Release
Mitchell | Genex Finalizes Coventry Workers' Comp Services Acquisition
Deal expands industry-leading solutions to boost better claims outcomes and improve lives for injured individuals
Workers' Comp
News Release
Mitchell Genex Finalizes Coventry Workers’ Comp Services Acquisition
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
Mitchell
Article
Workers’ Comp Data: Healthcare Industry Sector is the Source of the Majority of COVID-19 Claims
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Workers' Comp
Article
Therapeutic Alternatives—A Closer Look
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.